Indian Generic
There are no products to list.
Today, India firmly holds the status of the "pharmacy of the world," providing over 20% of the global export volume of generic medicines. At the heart of this massive industry stands Indian Generic—a symbol of technological progress and corporate social responsibility. The company's global mission is to create conditions where every individual, regardless of geographical location or income level, can access highly effective medications. Indian Generic specializes in developing drugs that are bioequivalent to original brands, significantly reducing patient costs without compromising therapy quality. This is particularly critical in men's health, where long-term treatment with original brands often becomes financially unsustainable. Thanks to the work of Indian scientists, modern medicine has become a tool for improving quality of life on a global scale.
The history of Indian Generic began with an ambitious vision of an integrated pharmaceutical complex. A fundamental milestone was the commissioning of its own finished dosage form manufacturing plant in 2002. The project was implemented in accordance with the strictest European GMP standards. Construction, which began in August 2002, was completed in just two years—a timeframe still considered a record for such complex facilities. This success allowed the company to organize a full-cycle production: from primary scientific research and synthesis of active molecules to packaging and international distribution. In 2006, production capacities quadrupled with the launch of the second phase. By 2017, the group's annual turnover surpassed 5 billion USD, confirming Indian Generic's status as a global market leader.
The Indian Generic production base is an embodiment of modern engineering solutions in pharmacy. Every workshop and laboratory is designed to ensure maximum purity and process precision. Adherence to GMP (Good Manufacturing Practice) protocols guarantees that every tablet manufactured meets the specified characteristics. Quality control starts at the raw material selection stage: Indian Generic collaborates only with certified suppliers of active pharmaceutical ingredients (APIs). The company's in-house R&D centers develop unique substance purification methods, minimizing side effects for the end consumer. Automated packaging lines and modern warehouse systems ensure full traceability of every batch, which is critical for exporting to countries with strict regulatory oversight, such as the USA, Canada, and the EU.
The most sought-after area of Indian Generic's activity is the production of treatments for sexual function correction. Sildenafil and Tadalafil produced by this company have become true bestsellers due to their reliability. Sildenafil (Viagra analog) from Indian Generic provides a powerful physiological response, acting predictably for 4-6 hours. In turn, Tadalafil (Cialis analog) offers men unprecedented freedom—its effect lasts up to 36 hours, allowing spontaneity to return to relationships. The company manufactures these drugs in various dosages, enabling the selection of an optimal treatment regimen for both single use and long-term therapy. The use of high-purity Indian raw materials ensures the bioequivalence of these generics to the original brands.
In addition to classic solutions, Indian Generic actively develops a line of next-generation drugs. Vardenafil (Levitra analog) is recognized by specialists as one of the safest options for men with diabetes due to its mild effect on the vascular system. Avanafil is a true gem of the assortment—a fourth-generation drug that starts acting within 15 minutes, a record for oral treatments. The company also offers Dapoxetine, the only officially approved treatment for premature ejaculation. These generics from Indian Generic help millions of men worldwide not only achieve a stable erection but also fully control the duration of intimacy, ensuring harmony for both partners.
The high technological level of Indian Generic has made the company a preferred partner for large international businesses. A significant portion of the plant's capacity is dedicated to contract manufacturing (White Label) for clients in North America and Europe. This means that Western pharmaceutical brands trust the Indian manufacturer to produce goods under their own trademarks. This trust is built on Indian Generic's impeccable reputation and its ability to pass the most complex quality audits. The status of an international exporter (IND GEN) allows India Export to promptly deliver products directly from Indian lines to the end consumer, ensuring direct import without intermediaries or hidden markups.
in Kyiv, Dnipro, Odessa, Khmelnytskyi, Zaporizhzhia, Mykolaiv, Lutsk, Kherson, Kryvyi Rih, Vinnytsia, Lviv, Kramatorsk, Kharkiv, Sumy, Mariupol, Chernivtsi, Chernihiv, Poltava, Ivano-Frankivsk, Donetsk, Luhansk, Kropyvnytskyi, Rivne, Zhytomyr, Ternopil.